OncoMark was founded with the specific purpose of translating the outputs of advanced research into biomarkers of cancer to the clinical and commercial setting. Our lead product, the OncoMasTR test, resulted from a successful collaboration between researchers at University College Dublin and Trinity College Dublin. The development of the test was clinically informed and enabled by a wide network of collaborators from multiple centers including Cancer Trials Ireland, Lund University and Key Opinion Leaders in the oncology field. We also had collaborations with the Netherlands Cancer Institute, Institute Curie, and the Vall D'Hebron Cancer Institute.